Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe plus atorvastatin versus atorvastatin alone after elective PCI
IRCT20171028037047N1Phase 4Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) and coronary arteriosclerosis comparing Atorvastatin + ezetimibe with Atorvastatin + placebo (2 arms). Primary endpoint: Myocardial infarction. Started Feb 2018; status: completed.
02
Drugs
ezetimibeatorvastatin
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20171028037047N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171028037047N1.